Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 10, 2001, Pages 1687-1697

  Dotan, I ^a,d   Hershkoviz, R ^b,c   Karmeli, F ^a   Brazowski, E ^a   Peled, Y ^a   Rachmilewitz, D ^a   Halpern, Z ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; IODOACETAMIDE; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; NITROBENZENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICOAGULANTS; BENZENESULFONATES; COLITIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENOXAPARIN; HEPARIN; IODOACETAMIDE; MALE; NITRIC OXIDE SYNTHASE; PEROXIDASE; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034794470     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01079.x     Document Type: Article

References (46)

1. Are the available low-molecular weight heparin preparations the same?
2. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins
3. Pharmacology and special clinical applications of low molecular weight heparins
4. Effect of heparin, dermatan sulfate and related oligo-derivatives on human polymorphonuclear leukocyte function
5. Heparin beyond its traditional role as an anticoagulant
6. Treatment of concanavalin-A induced hepatitis in mice with low molecular weight heparin
7. Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic Coxsackievirus B3-induced myocarditis in A/J mice
8. Heparin disaccharides inhibit tumor necrosis factor-α production by macrophages and arrest immune inflammation in rodents
9. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins
10. Heparin and modified heparin inhibit complement activation in vivo
11. Low doses of low molecular weight heparin inhibit in vivo the elicitation of contact hypersensitivity
12. Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: A preliminary report
13. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5
14. Heparin therapy in refractory ulcerative colitis - An update
15. Anti-inflammatory properties of unfractionated heparin in patients with highly active ulcerative colitis: A pilot study
16. Paradoxical response to heparin in 10 patients with ulcerative colitis
17. Unfractionated heparin in the therapy of patients with highly active inflammatory bowel disease
18. A multi-center, randomized, controlled trial of heparin for the treatment of ulcerative colitis
19. Low molecular weight heparin (LMWH) treatment in steroid refractory ulcerative colitis (U.C)
20. Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction
21. Coagulation studies in ulcerative colitis and Crohn's disease
22. Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements
23. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis
24. Sulfhydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase
25. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker
26. Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine
27. Role of prostaglandins in ulcerative colitis: Enhanced production during active disease and inhibition by sulfasalazine
28. Inhibitory effects of low molecular weight heparin on mediator release by mast cells: Preferential inhibition of cytokine production and mast cell-dependent cutaneous inflammation
29. The hemorrhagic effect of low molecular weight heparins, dermatan sulphate and hirudin
30. Haemorrhagic effects of unfractionated and two low molecular weight heparins, enoxaparin and fragmin, in rats
31. Anti-inflammatory effects of heparin and its derivatives: Inhibition of complement and of lymphocyte migration
32. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation
33. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF binding protein I by heparin
34. A disaccharide that inhibits tumor necrosis factor-α is formed from the extra cellular matrix by the enzyme heparinase
35. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparinase from human neutrophils. Possible role in invasion through basement membranes
36. Activated T lymphocytes produce a matrix-degrading heparan sulfate endoglycosidase
37. Inhibition of heparinase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species
38. 'Sticky' neutrophils, pathergic arthritis and response to heparin in pyoderma gangrenosum complicating ulcerative colitis
39. Serum basic fibroblast growth factor in pediatric Crohn's disease - Implications for wound healing
40. Expression of syndecan-1 in inflammatory bowel disease and a potential mechanism of heparin therapy
41. Cell surface, heparin-like molecules are required for binding basic fibroblast growth factor to its high affinity receptor
42. Heparin cell adhesion and pathogenesis of inflammatory bowel disease
43. Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy
44. Hapten induced model of chronic inflammation and ulceration in the rat colon
45. The effect of heparin on trinitrobenzene sulphonic acid induced colitis in the rat
46. Effect of heparin on dextran sulfate sodium induced colitis